Who Owns Emergent BioSolutions Stock?
NYSE: EBSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 90.69%
- Held by insiders
- 4.21%
- Institutional holders
- 265
- Institutions 90.7%
- Insiders 4.2%
- Public and other 5.1%
Who owns Emergent BioSolutions stock?
Institutional investors own about 90.7% of Emergent BioSolutions's shares, spread across 265 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 4.21% of EBS.
The largest institutional holders are Blackrock Inc. (9.20%), Dimensional Fund Advisors LP (6.00%) and State Street Corporation (5.71%). Together, the top 10 institutions control 43.7% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their EBS positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of EBS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 4.72M | 9.20% | +8.6% |
| Dimensional Fund Advisors LP | 3.08M | 6.00% | +11.6% |
| State Street Corporation | 2.93M | 5.71% | +2.8% |
| American Century Companies Inc | 2.77M | 5.40% | +14.2% |
| Vanguard Capital Management LLC | 2.20M | 4.29% | -2.6% |
| LSV Asset Management | 1.70M | 3.31% | +89.1% |
| Acadian Asset Management. LLC | 1.34M | 2.62% | -2.7% |
| Geode Capital Management, LLC | 1.34M | 2.61% | +5.0% |
| Charles Schwab Investment Management, Inc. | 1.20M | 2.34% | -20.3% |
| Oak Hill Advisors, L.P. | 1.11M | 2.17% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of EBS
| Fund | Shares | % Held |
|---|---|---|
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 2.79M | 5.44% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.80M | 3.51% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.55M | 3.03% |
| iShares Trust-iShares Russell 2000 ETF | 1.36M | 2.66% |
| SCHWAB STRATEGIC TRUST-Schwab Fundamental U.S. Small Company ETF | 757.64K | 1.48% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Value Portfolio | 705.56K | 1.38% |
| Federated Hermes MDT Series-Federated Hermes MDT Small Cap Core Fund | 630.32K | 1.23% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 592.78K | 1.16% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 569.09K | 1.11% |
| Fidelity Covington Trust-Fidelity Enhanced Small Cap Core ETF | 529.84K | 1.03% |
Frequently asked questions
Who is the largest shareholder of Emergent BioSolutions?
Blackrock Inc. is the largest institutional shareholder of EBS, owning 9.20% of shares outstanding (4.72M shares) as of its latest 13F filing.
What percentage of Emergent BioSolutions is owned by institutions?
Institutions own about 90.7% of EBS shares and 94.7% of the public float.
How much of Emergent BioSolutions do insiders own?
Insiders, such as officers and directors, own about 4.21% of EBS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.